ALLMedicine™ Hyperkalemia Center
Research & Reviews 1,594 results
https://doi.org/10.1007/s10047-023-01382-3
Journal of Artificial Organs : the Official Journal of Th... Yamana F, Domae K et. al.
Jan 28th, 2023 - Although veno-arterial extracorporeal membrane oxygenation (VA-ECMO) has been used to aid myocardial recovery in patients with postcardiotomy cardiogenic shock (PCCS), it has been associated with adverse effects. The combined use of VA-ECMO and Im...
https://doi.org/10.2174/1871525721666230125091826
Cardiovascular & Hematological Agents in Medicinal Chemis... Zardast M, Behmanesh K et. al.
Jan 27th, 2023 - Digoxin poisoning commonly occurs in people treated with digoxin. It has been suggested that treatment with dantrolene may be a suitable strategy for digoxin-induced cardiotoxicity. The aim of this study was to evaluate the protective effect of da...
https://clinicaltrials.gov/ct2/show/NCT05090865
Jan 26th, 2023 - The kidney is a primary site of potassium regulation in the body. Hyperkalemia, elevated serum potassium, occurs in approximately 10% of patients with chronic kidney disease (CKD) and is associated with elevated all-cause mortality. To minimize th...
https://www.ncbi.nlm.nih.gov/pubmed/36689973
American Family Physician; Kim MJ, Valerio C et. al.
Jan 24th, 2023 - Hypokalemia and hyperkalemia occur when serum potassium levels are less than 3.5 mEq per L or greater than 5.0 mEq per L, respectively. The World Health Organization recommends a potassium intake of at least 3,510 mg per day for optimal cardiovasc...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9881823
Current Opinion in Nephrology and Hypertension; Adomako EA, Maalouf NM
Jan 24th, 2023 - The present review summarizes findings of recent studies examining the epidemiology, pathophysiology, and treatment of type 4 renal tubular acidosis (RTA) and uric acid nephrolithiasis, two conditions characterized by an abnormally acidic urine. B...
Guidelines 1 results
https://doi.org/10.1016/j.cjca.2016.02.066
The Canadian Journal of Cardiology; Leung AA, Nerenberg K et. al.
Apr 28th, 2016 - Hypertension Canada's Canadian Hypertension Education Program Guidelines Task Force provides annually updated, evidence-based recommendations to guide the diagnosis, assessment, prevention, and treatment of hypertension. This year, we present 4 ne...
Drugs 206 results see all →
Clinicaltrials.gov 141 results
https://clinicaltrials.gov/ct2/show/NCT05090865
Jan 26th, 2023 - The kidney is a primary site of potassium regulation in the body. Hyperkalemia, elevated serum potassium, occurs in approximately 10% of patients with chronic kidney disease (CKD) and is associated with elevated all-cause mortality. To minimize th...
https://clinicaltrials.gov/ct2/show/NCT01712620
Jan 23rd, 2023 - INTRODUCTION: Pulmonary arterial hypertension (PAH) is a rare disorder associated with poor survival. Endothelial dysfunction resulting from 1) genetic susceptibility, and 2) a triggering stimulus that initiates pulmonary vascular injury, the two-...
https://clinicaltrials.gov/ct2/show/NCT04676646
Jan 23rd, 2023 - REALIZE-K is a Phase 4, multinational, multicenter, double-blind, placebo-controlled, randomized-withdrawal, parallel-group study that includes the following 3 phases: screening, 4-6 week open-label run-in phase where sodium zirconium cyclosilicat...
https://clinicaltrials.gov/ct2/show/NCT05348733
Jan 20th, 2023 - This is an observational study in people with chronic kidney disease (CKD) and type 2 diabetes (T2D) who will be receiving finerenone. Kidneys filter extra water and waste out of the blood and make urine. CKD is a long-term, progressive, decrease ...
https://clinicaltrials.gov/ct2/show/NCT05408039
Jan 20th, 2023 - This study is a multinational, observational, prospective, longitudinal, cohort study that will include primary and secondary data collection. Secondary data, collected as per routine clinical practice will be extracted from electronic health reco...
News 366 results
https://www.medscape.com/viewarticle/983607
Nov 5th, 2022 - ORLANDO, Florida — Treatment with a renin-angiotensin system (RAS) inhibitor is widely accepted as standard practice for slowing progression of chronic kidney disease (CKD), but data have been inconsistent as to whether there is benefit to continu...
https://www.mdedge.com/dermatology/article/258171/business-medicine/expert-calls-thoughtful-approach-curbing-costs
Doug Brunk
Sep 22nd, 2022 - PORTLAND, ORE. – About 10 years ago when Arash Mostaghimi, MD, MPA, MPH, became an attending physician at Brigham and Women’s Hospital, Boston, he noticed that some of his dermatology colleagues checked the potassium levels religiously in their fe.
https://www.onclive.com/view/adagrasib-with-or-without-cetuximab-elicits-responses-in-advanced-kras-g12c-mutated-crc
Sep 12th, 2022 - Adagrasib (MRTX849) monotherapy and in combination with cetuximab (Erbitux) generated encouraging responses in patients with advanced colorectal cancer (CRC) harboring KRAS G12C mutations, according to data from the phase 1b/2 KRYSTAL-1 trial (NCT...
https://www.mdedge.com/fedprac/avaho/article/257554/hematology/discontinuation-allopurinol-tumor-lysis-syndrome-report
Yasmine Ayoub, Sara Gordon et. al.
Sep 2nd, 2022 - Background/Purpose Tumor lysis syndrome (TLS) is caused by the release of intracellular products into the blood following rapid lysis of malignant cells resulting in hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. Complications o.
https://www.mdedge.com/fedprac/avaho/article/257528/oncology/not-just-castleman-disease-elusive-diagnosis-tafro-syndrome
Shashank Sama, Lindsey Fitzgerald et. al.
Sep 1st, 2022 - Introduction Idiopathic multicentric Castleman disease (iMCD) cases with thrombocytopenia (T), anasarca (A), Fever (F), reticulin fibrosis (R), and organomegaly (O) are considered a subtype of iMCS called TAFRO syndrome. It is a rare syndrome char.